CHGCF - Chugai Pharmaceutical Co. Ltd. (CHGCF) CEO Tatsuro Kosaka on Q4 2020 Results - Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2020 Earnings Conference Call February 04, 2021 04:00 AM ET Company Participants Tatsuro Kosaka - Chairman & Chief Executive Officer Toshiaki Itagaki - Executive Vice President & Chief Financial Officer Tomoyuki Igawa - Chief Executive Officer & Research Head of Chugai Pharmabody Research Pte. Ltd. Singapore Tetsuya Yamaguchi - Vice President, Head of Business Development Osamu Okuda - President & Chief Operating Officer Shinji Hidaka - Vice President & Head of Marketing & Sales Division Conference Call Participants Kazuaki Hashiguchi - Daiwa Securities Fumiyoshi Sakai - Credit Suisse Shinichiro Muraoka - Morgan Stanley Naoya Miura - Jefferies Securities Presentation Tatsuro Kosaka I am Tatsu Kosaka, Chairman and CEO. I'm going to give you the review of 2020 and the general overview of IBI 21, our midterm business plan. Last year due to COVID-19, the whole world faced an unprecedented crisis. Our company was also

For further details see:

Chugai Pharmaceutical Co., Ltd. (CHGCF) CEO Tatsuro Kosaka on Q4 2020 Results - Earnings Call Transcript